Patents by Inventor Paul Porwen Hung

Paul Porwen Hung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040002137
    Abstract: This invention features a nucleic acid expression vector that includes a bicistronic coding unit that comprises a first segment that encodes a human tissue urokinase plasminogen activator protein and a second segment that encodes an amplifiable dominant selectable marker (e.g., dihydrofolate reductase); and a promoter (e.g., a cytomegalovirus promoter) operably linked to the bicistronic coding unit.
    Type: Application
    Filed: March 27, 2003
    Publication date: January 1, 2004
    Applicant: Global Biotech, Inc. a Taiwan corporation
    Inventors: Paul Porwen Hung, Bryan T. H. Wu
  • Publication number: 20030077682
    Abstract: This invention relates to an anhydrous arginine-free formulation including human tissue urokinase type plasminogen activator, lysine, phosphoric acid, and a non-ionic detergent, wherein the human tissue urokinase type plasminogen activator, lysine, phosphoric acid, and non-ionic detergent are in quantities of 10-60 mg, 100-700 mg, 20-100 mg, and 0.2-5 mg, respectively; or in quantities of the same relative ratio.
    Type: Application
    Filed: September 5, 2002
    Publication date: April 24, 2003
    Inventors: Paul Porwen Hung, Kenneth S. S. Chang, Bryan T. H. Wu, Kuo-Kuei Huang
  • Publication number: 20020187944
    Abstract: A method of inhibiting a human immunodeficiency virus reverse transcriptase by contacting the reverse transcriptase with an effective amount of 9-O-methyl oxime erythromycin A.
    Type: Application
    Filed: March 21, 2002
    Publication date: December 12, 2002
    Inventor: Paul Porwen Hung